Biocon receives approval for Insulin Glargine in Mexico through its partner PiSA Farmaceutica
The combined market for Insulin Glargine in Mexico is estimated to be in excess of $40 million
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.